HYDROGEL FORMULATION COMPRISING ZEBULARINE AND RETIONIC ACID

HYDROGEL FORMULATION COMPRISING ZEBULARINE AND RETIONIC ACID

A pharmaceutical composition comprising two hydrogel formulations with biologically active substances for simultaneous use, one mixture of which comprises not less than 60 and not more than 240 mg of zebularine added to 1 ml of sodium alginate hydrogel, and the other mixture of which comprises not l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sass, Piotr, Baczynski-Keller, Jakub, Sachadyn, Pawel, Slonimska, Paulina, Dzierzynska, Maria, Pikula, Michal, Deptula, Milena, Skowron, Piotr, Sawicka, Justyna, Kaminska, Jolanta, Rodziewicz-Motowidlo, Sylwia, Platek, Rafal, Sosnowski, Pawel
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A pharmaceutical composition comprising two hydrogel formulations with biologically active substances for simultaneous use, one mixture of which comprises not less than 60 and not more than 240 mg of zebularine added to 1 ml of sodium alginate hydrogel, and the other mixture of which comprises not less than 1 and not more than 4 mg of retinoic acid added to 1 ml of sodium alginate hydrogel, wherein the biologically active substances, i.e. zebularine and retinoic acid, release gradually from each formulation due to hydrogel biodegradation, which allows their combined action to be used to stimulate complex tissue regeneration.